Aurobindo Pharma to expand product basket; eyes $3 billion revenues by FY18
Aurobindo PharmaBSE 3.68 % is targetting a revenue of over $ 3 billion (over Rs 19,800 crores) by 2017-18 and plans to expand its basket with new drugs to treat cancer and hormonal diseases, as also with various nutraceuticals and Over The Counter (OTC) products.
Read more at:…
Aurobindo Pharma to expand product basket; eyes $3 billion revenues by FY18
| Subscribe To Our Free Newsletter |
